Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-dose Testosterone in Men With Metastatic Castration-resistant Prostate Cancer and ATM or CDK12 Deficiency

NCT05011383 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT05011383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05011383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-dose Testosterone in Men With Metastatic Castration-resistant Prostate Cancer and ATM or CDK12 Deficiency
Lead sponsor
VA Office of Research and Development
Phase
Phase 2
Overall status
Recruiting
Start date
August 31, 2021
Completion date
August 31, 2027
Enrollment
51 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate cancer